Fluorescence Detection of Colon Dysplasia in Mice
Author Information
Author(s): Sharon J. Miller, Bishnu P. Joshi, Ying Feng, Adam Gaustad, Eric R. Fearon, Thomas D. Wang
Primary Institution: University of Michigan
Hypothesis
Can novel peptides specifically target dysplastic colonic epithelium in vivo?
Conclusion
The study successfully identified a peptide that binds specifically to dysplastic lesions in the colon, enhancing detection methods for pre-malignant lesions.
Supporting Evidence
- The peptide QPIHPNNM binds approximately 2-fold greater to dysplastic lesions compared to a control peptide.
- Fluorescence endoscopy showed enhanced binding of the target peptide to colonic adenomas.
- The study utilized a genetically engineered mouse model that develops adenomas in the distal colon.
Takeaway
Researchers found a special peptide that can stick to bad cells in the colon, helping doctors see early signs of cancer better.
Methodology
The study used phage display to identify a peptide that binds to dysplastic colonic mucosa in a genetically engineered mouse model, followed by in vivo and ex vivo validation using fluorescence endoscopy.
Limitations
The peptide did not bind to minimally raised lesions, which may limit its effectiveness in certain cases.
Participant Demographics
CPC;Apc genetically engineered mice
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website